Below are the 2013 participating companies. To see the list of 2012 participating companies, click here.
| 4P Therapeutics |
| 5AM Ventures |
| Accele Biopharma, Inc. |
| Achaogen, Inc. |
| ADM Diagnostics, LLC |
| Affimed Therapeutics AG |
| Akron Molecules GmbH |
| Alethia Biotherapeutics Inc. |
| Alios Biopharma, Inc. |
| Alta Partners |
| Altheus Therapeutics, Inc. |
| Altravax, Inc. |
| Ambit Biosciences |
| Ambrx Inc. |
| America Stem Cell Inc. |
| Amgen Inc. |
| AM-Pharma B.V. |
| Angiochem |
| Anthrocell Pty |
| Apposite Capital |
| Aquilo Capital |
| Aquinox Pharmaceuticals, Inc. |
| Armour Therapeutics Inc |
| Ash Stevens Inc. |
| Astellas Pharma Inc. |
| Astex Pharmaceuticals, Inc. |
| AstraZeneca |
| Asuragen, Inc. |
| Asymmetry Global Healthcare |
| ATEL Ventures |
| Athyrium Capital Management |
| Atossa Genetics, Inc. |
| Auspex Pharmaceuticals, Inc |
| AvidBiotics Corp. |
| BASF Venture Capital |
| Bavarian Nordic, A/S |
| Baxter International Inc |
| Baxter Ventures |
| Bay City Capital |
| BayBio |
| BDC Capital Healthcare Fund |
| BEAT Biotherapeutics Corp. |
| Bellicum Pharmaceuticals, Inc. |
| Bijan Capital |
| BioCrea |
| Biodesy LLC |
| BioMed Ventures |
| BiomedTracker |
| Bio-Path Holdings, Inc. |
| BioWorld Today |
| Blaise Group International |
| Boehringer Ingelheim Pharmaceutical, Inc |
| Breakout Labs/ Thiel Foundation |
| Bristol-Myers Squibb |
| Burrage Capital |
| Burrill & Company |
| Business Development Bank of Canada |
| Business Wire |
| BVF L.P. |
| BWS Financial Inc. |
| CanaccordGenuity |
| Capital Royalty L.P. |
| Catalyst Pharmaceutical Partners |
| Cato BioVentures |
| Cerecor Inc. |
| CertiChem, Inc |
| CG Pharmaceuticals, Inc |
| Chubb Group of Insurance Companies |
| Cipher Pharmaceuticals Inc. |
| Clinical Persona, Inc. |
| Colo. Inst. for Drug Device & Diag. Dev. |
| Conatus Pharmaceuticals |
| Confluence Life Sciences, Inc |
| Consulate General of Canada |
| Contrafect |
| Corium International, Inc |
| Coyote Pharmaceuticals |
| Critical Outcome Technologies Inc. |
| Cureduchenne |
| Cyclica Therapeutics Inc |
| CytomX Therapeutics, Inc. |
| Dalton Pharma Services |
| Danken Ventures |
| Dectiva |
| Dentons |
| diaDexus, Inc. |
| DiaMedica |
| Dicerna Pharmaceuticals |
| Dillon Capital Strategies |
| DiscoveryBioMed, Inc |
| Dorset Capital LLC |
| EBD Group |
| EcoR1 Capital, LLC |
| Edison Investment Research |
| EGEN, Inc |
| EicOsis, LLC |
| ELEISON PHARMACEUTICALS LLC |
| Eli Lilly and Company |
| Elsevier Business Intelligence |
| Elusys Therapeutics |
| Enso Ventures |
| Epirus Biopharmaceuticals, Inc. |
| EPISTAT |
| Esperion Therapuetics, Inc. |
| Evotec International GmbH |
| Fate Therapeutics, Inc. |
| Fenwick & West LLP |
| Five Prime Therapeutics |
| Forest Laboratories, Inc. |
| FORMA Therapeutics |
| Four Oaks Partners |
| FPRT Bio |
| Franklin Templeton Investments |
| Frazier Healthcare Ventures |
| GE capital |
| Gemmus Pharma Inc. |
| GeneCentric Diagnostics, Inc |
| Genenews |
| GenSpera, Inc. |
| Georgia State University Research Foundation |
| GlobeImmune, Inc. |
| GLYCOMIMETICS, INC. |
| Greenwich LifeSciences |
| Halsa Pharmaceuticals |
| Healthy Living Magazine |
| Heat Biologics |
| Helix Ventures |
| HepSeeVax |
| Hightech Reports |
| Horizon Pharma |
| Hua Medicine |
| Igenica, Inc |
| immatics biotechnologies GmbH |
| Immune Design |
| IMMUNE Pharmaceuticals Inc |
| Immunovaccine |
| INanoBio |
| Innotrove LLC |
| Innovus Pharmaceuticals, Inc. |
| inovation ventures |
| Inovio Pharmaceuticals |
| InSymbiosis |
| Integrium |
| International Finance Corporation |
| International Stem Cell Corporation |
| Inventis Investment Holdings (China) Ltd |
| Investor Growth Capital |
| IPF Partners |
| Jade Therapeutics, Inc. |
| Janssen Pharmaceutical Companies of John |
| Jennerex, Inc. |
| Johnson & Johnson |
| JT Pharma |
| Kala Pharmaceuticals |
| KangLaiTe USA Inc |
| Karolinska Development AB (publ.) |
| Kearny Venture Partners |
| KineMed, Inc |
| Kissei America, Inc |
| KMA & Company |
| Knobbe Martens Olson & Bear LLP |
| Knoll Capital Management LLC |
| KPCB |
| KVP |
| La Jolla Pharmaceutical Company |
| Labrys Biologics, Inc. |
| Latterell Venture Partners |
| Leading Biosciences, Inc. |
| Life Science Angels |
| Life Science Leader |
| Lion Biotechnologies |
| Livwel Therapeutics Inc |
| Longitude Captial |
| Lumira Capital |
| MabVax Therapeutics, Inc. |
| Mast Therapeutics, Inc. |
| Maverix Biomics, Inc. |
| MAX BioPharma Inc. |
| MaxCyte |
| Medical Technology Stock Letter |
| MedPanel Capital Advisors |
| Menogenix, Inc. |
| Mercadyne Investments, LLC |
| Merck |
| Mercury Fund |
| Mergermarket |
| Microbiotix, Inc. |
| Milestone Capital |
| Mirna Therapeutics, Inc |
| Mission Bay Capital |
| Mitsubishi Corporation |
| Mizuho Securities USA |
| Mochida Pharmaceutical |
| Momenta Pharmaceuticals, Inc. |
| Morgan Lewis & Bockius LLP |
| Morphochem AG |
| MP Healthcare Venture Management, Inc. |
| MPM Capital |
| Muse Capital |
| MustangVC |
| MyeloRx LLC |
| Nano3D Biosciences, Inc. |
| Nanofiber Solutions |
| NEA |
| NeoStem |
| Neuraltus Pharmaceuticals, Inc. |
| New Biology Ventures, LLC |
| New Enterprise Associates |
| NEWGEN THERAPEUTICS, INC. |
| Next Big Thing Investor.com |
| NGN Capital LLC |
| NLV |
| NLVP |
| NOVARTIS |
| Novartis Venture Fund |
| NovelMed Therapeutics, Inc. |
| Numab AG |
| Numoda Capital Innovations |
| Ocera Therapeutics, Inc |
| OncologyLink news-n-notes |
| OncoMed Pharmaceuticals, Inc. |
| OncoSec Medical |
| Ontario Government |
| Onyx Pharmaceuticals |
| Opsona Therapeutics Ltd. |
| Opus Point Partners |
| Orange County Research Center |
| OrbiMed Advisors |
| Oxford Bioscience Partners |
| Oxigene |
| OxThera AB |
| Palatin Technologies, Inc. |
| Palo Alto Investors |
| Parabon NanoLabs |
| ParinGenix, Inc. |
| Patrys Limited |
| Piper Jaffray & Co |
| Poliwogg |
| Polynoma |
| PreScience Labs |
| Principia Biopharma |
| Probiodrug AG |
| Protagonist Therapeutics Inc. |
| Proteon Therapeutics, Inc. |
| Purdue Pharma LP |
| Quest PharmaTech Inc |
| Questcor Pharmaceuticals, Inc |
| QVT |
| Radius Health, Inc |
| RECARDIO |
| Regado Biosciences, Inc. |
| Resverlogix |
| ROTH Capital Partners |
| Russo Partners |
| RXi Pharmaceuticals |
| S1 Biopharma |
| S1 Biopharma, Inc. |
| Sagient Research |
| San Diego Tech Coast Angels |
| San Francisco Business Times |
| SantA Ventures |
| ScarX Therapeutics |
| scendiant |
| Science Futures |
| Scrip Intelligence |
| Sensorion |
| Sernova Corp |
| Shinyusha Publishing |
| Sialix |
| Sirona Biochem |
| SironRX Therapeutics, Inc. |
| Slater Technology Fund |
| Sofinnova Ventures |
| Sophiris Bio, Corp |
| Spring Bank Pharmaceuticals |
| SR One, Limited |
| Stemina Biomarker Discovery |
| Stiftelsen Industrifonden |
| Strategy Signal LLC |
| Sutro Biopharma, Inc |
| SVB |
| Syndax Pharmaceuticals, Inc. |
| Syzygy Therapeutics |
| Tavistock Group |
| Tech Coast Angels |
| TeraDiscoveries, Inc |
| The Burrill Report |
| The Conafay Group |
| The Life Sciences Report |
| The Scripps Research Institute |
| The Trout Group LLC |
| Theraclone Sciences, Inc |
| TherapeuticsMD.com |
| TheraVasc Inc. |
| Third Rock Ventures |
| Thorner Ventures |
| three arch |
| TissueGene, Inc. |
| Topica Pharmaceuticals, Inc. |
| TriplePoint Capital |
| Tymora Analytical Operations |
| Tynan Consulting |
| UCSF |
| US Venture Partners |
| Vaccinex |
| Valence Life Sciences |
| Vascular Pharmaceuticals |
| Versant Ventures |
| Versartis, Inc. |
| viDA Therapeutics Inc |
| Viking Therapeutics, Inc. |
| Visionary Pharmaceuticals |
| Vista Partners LLC |
| Vivaldi Biosciences Inc. |
| Vivo Ventures |
| VWR International, LLC |
| Wall Street Journal |
| WCG |
| William Harris Investors |
| WRF Capital |
| www.carmot.us |
| Xalud Therapeutics, Inc. |
| Zafgen |
| ZIOPHARM Oncology, Inc |
| Zymeworks Inc. |
*Updated 9/30/2013